Obstructive sleep apnea has been linked to an increased risk of dementia in a new study—and the association was particularly ...

Each year, more than 200 million catheters are used worldwide to treat vascular diseases, including heart disease and artery ...

Vivos' cost-cutting initiatives also led to a $1 million or 27% year-over-year reduction in operating loss, versus the third quarter of 2023. For the nine months ended September 30, 2024 operating ...

As we age, our sleep needs and habits change. While we tend to sleep more in our younger years, this gradually decreases as ...

Researchers released new clinical guidelines for treating restless legs syndrome (RLS), emphasizing patient-centered care and ...

Therapeutic strides in biotech are advancing promising candidates in clinic to address different stages of sleep apnea and ...

The Neuromodulation segment designs and markets NM-based medical devices for the treatment of epilepsy, depression, and obstructive sleep apnea. The Other segment consists ... information technology, ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

The findings offer promising support for progressing ADPO-002NP treatment to first-in-human Phase I clinical trials. Adipo ...

Drug therapy: A new study, recently published ... medication Mounjaro and weight loss treatment Zepbound – helps reduce ...